|
2025
|
P/S
|
Pharmaceutical preparations. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; p... |
|
|
P/S
|
Medicinal drinks; lacteal flour for babies; nutritional supplements; dietary supplements; food su... |
|
|
P/S
|
Pharmaceutical preparations; medicinal drinks; lacteal flour
for babies; nutritional supplements... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceu... |
|
|
P/S
|
Pharmaceutical preparations; diagnostic preparations for
medical purposes; diagnostic reagents f... |
|
|
P/S
|
Diagnostic preparations for medical purposes; diagnostic reagents for medical use Providing medic... |
|
|
P/S
|
Non-medicated skin serums; Beauty serums |
|
|
Invention
|
Pyrimidine compound.
The present invention provides a novel pyrimidine compound represented by F... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of central nervous system diseases and disorders, c... |
|
|
Invention
|
Centanafadine pharmaceutical formulations, and methods of making and using same.
Pharmaceutical ... |
|
|
Invention
|
Method of detecting conjunctival disease using ocular surface tissue, and aging biomarker.
A met... |
|
|
Invention
|
Methods for producing aripiprazole suspension and freeze-dried formulation.
Disclosed are a meth... |
|
|
Invention
|
Heterocyclic compounds for the treatment of epilepsy.
The present invention provides a method fo... |
|
|
Invention
|
Methods of dispersing aripiprazole injectable preparations.
The present disclosure is directed t... |
|
|
Invention
|
Functional compound. Provided is a novel compound useful for, e.g., comprehensive analysis of cel... |
|
|
Invention
|
Orally administered substance and method for producing same, and magnetic ink used to produce ora... |
|
|
Invention
|
Tetrahydropyrazolopyridine derivative. The present invention relates to tetrahydropyrazolopyridin... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of kidney diseases |
|
|
Invention
|
Oxazole compound crystal.
Provided is a crystal of a specific oxazole compound that has specific... |
|
|
P/S
|
Breath freshening preparations for personal hygiene; soap;
cosmetic soaps; facial soaps; facial ... |
|
|
P/S
|
Soap; cosmetic soaps; dentifrices; toilet water; lotions for
cosmetic purposes; skin lotion; hai... |
|
|
P/S
|
Skin soap; cosmetic soaps; dentifrices; toilet water; lotions for cosmetic purposes; skin lotion;... |
|
|
Invention
|
Mesenchymal cells of ventral hindgut mesoderm and method for producing same. This method for prod... |
|
|
Invention
|
Use of centanafadine in treatment of adhd symptoms. Methods of using centanafadine in treating AD... |
|
|
P/S
|
Medical apparatus and instruments for use in diagnosing and monitoring vital signs of patients wi... |
|
|
Invention
|
Quabodepistat-containing composition. Provided is a composition in the form of a suspension of su... |
|
|
Invention
|
Delamanid-containing composition. Provided is a composition in the form of a suspension of submic... |
|
|
Invention
|
Quabodepistat-containing composition. Provided is a composition in the form of a suspension of mi... |
|
|
P/S
|
Cardiovascular treatment preparations; Cardiovascular pharmaceutical preparations; Ophthalmic pre... |
|
|
Invention
|
Piperidine- and morpholine-carboxylate compounds as sort1 inhibitors. Disclosed are compounds, or... |
|
|
Invention
|
Sheet-like cell culture and method for producing same. To provide a method for producing a sheet-... |
|
|
P/S
|
Pharmaceutical preparations; pharmaceutical preparations for
the treatment of central nervous sy... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of central nervous system diseases and disorders |
|
|
P/S
|
Anti-psychotics; central nervous system stimulants; central nervous system depressants; pharmaceu... |
|
|
Invention
|
Suspension for oral administration comprising amorphous tolvaptan.
This invention provides a sus... |
|
2024
|
Invention
|
Antitumor composition.
A combination of antitumor agents significantly shrinks tumors by synergi... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical pr... |
|
|
Invention
|
Injectable formulation.
An object of the present invention is to provide a sustained-release inj... |
|
|
Invention
|
Sleep improving agent.
Provided is a heat shock protein expression-inducing agent, more specific... |
|
|
Invention
|
Processes for making intermediates for isoindolinone inhibitors of the mdm2-p53 interaction havin... |
|
|
Invention
|
Pharmaceutical compositions including a mdm2-p53 inhibitor. The present disclosure relates to pha... |
|
|
Invention
|
Freeze-dried aripirazole formulation.
An object of the present invention is to provide a freeze-... |
|
|
Invention
|
Chimeric antigen receptor. Provided is a novel chimeric antigen receptor. This chimeric antigen r... |
|
|
Invention
|
Compounds as csf1r inhibitors. Disclosed are pyrazolopyridine or pyrazolopyrimidine compounds, or... |
|
|
Invention
|
Benzazepine derivatives.
Provided are novel benzazepine compounds of Formula (1), or salts there... |
|
|
P/S
|
Soy-based nutrition food bars; soy-based meal replacement food bars. |
|
|
Invention
|
Centanafadine pharmaceutical formulations, and methods of making and using same. Pharmaceutical f... |
|
|
Invention
|
Frozen dessert composition.
The disclosure provides a frozen dessert composition including (A) a... |
|
|
Invention
|
Combinations comprising brexpiprazole or a salt thereof and a second drug for use in the treatmen... |
|
|
Invention
|
Oral pharmaceutical composition containing heterocyclic compound.
Provided is a means that is ca... |
|
|
Invention
|
Delamanid-containing composition.
Provided is a composition comprising delamanid particles for w... |
|
|
Invention
|
Oral pharmaceutical composition.
Provided is a means that is capable of preventing initial exces... |
|
|
Invention
|
4-(methylaminophenoxy)pyrdin-3-yl-benzamide derivatives for treating cancer.
The present inventi... |
|
|
Invention
|
Fixed dose combinations of cedazuridine and azacitidine. The present disclosure relates generally... |
|
|
Invention
|
Solution for oral administration.
Provided is a solution suitable for oral administration of 7-[... |
|
|
Invention
|
Pharmaceutical compositions including tolinapant and packaging. The present disclosure relates ge... |
|
|
Invention
|
Prophylactic and/or therapeutic agent for behavioral and psychological symptoms associated with n... |
|
|
Invention
|
Composition for treating and/or preventing hearing impairment. Provided is: a composition for tre... |
|
|
Invention
|
Therapeutic agent for nonalcholic stetohepatitis. The present invention relates to a safe and eff... |
|
|
P/S
|
Non-medicated soaps and detergent soaps; Cosmetics and non-medicated toiletry preparations; Facia... |
|
|
Invention
|
Injectable preparation.
An object of the present invention is to provide a storage-stable inject... |
|
2023
|
Invention
|
Microorganism belonging to genus akkermansia.
The present invention relates to a microorganism b... |
|
|
Invention
|
Computer program, and information processing device and method.
Provided is a computer program, ... |
|
2022
|
Invention
|
Composition for improving sleep quality or controlling autonomic nervous system.
A novel means f... |
|
|
Invention
|
Compositions comprising an erk inhibitor.
The present disclosure relates generally to compositio... |
|
|
Invention
|
Acridine compound.
A compound represented by formula [I]:
A compound represented by formula [I... |
|
|
Invention
|
Water-soluble phytin.
The present application provides a phytin with improved solubility in wate... |
|
|
Invention
|
Combination drug.
The present invention discloses administering pharmaceutical compositions in c... |
|
|
Invention
|
Hydrogenated quinoxalines.
Provided is a therapeutic agent for ADHD having an efficacy comparabl... |
|
2021
|
Invention
|
Composition for preventing or treating deterioration in brain function or maintaining or improvin... |
